The efficacy of liposomal bupivacaine compared with traditional peri-articular injection for pain control following total knee arthroplasty: an updated meta-analysis of randomized controlled trials
- PMID: 31253119
- PMCID: PMC6599357
- DOI: 10.1186/s12891-019-2660-7
The efficacy of liposomal bupivacaine compared with traditional peri-articular injection for pain control following total knee arthroplasty: an updated meta-analysis of randomized controlled trials
Abstract
Background: The efficacy of postoperative pain management is an important factor that influences the final outcome of total knee arthroplasty (TKA). Whether liposomal bupivacaine offers better efficacy compared with traditional peri-articular injection after TKA remains inconclusive. We conduct this study to compare the true efficacy of liposomal bupivacaine (LB) with traditional peri-articular injection (TPAI) following TKA.
Materials and methods: Randomized controlled trials (RCTs) from PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials (CENTRAL) and Web of Science were searched. Thirteen RCTs involving 1373 patients were finally included in our meta-analysis (LB = 691, TPAI = 682). The continuous and dichotomous outcome were collected in a standard form, and the data were analysed by using Review Manager 5.3 software. Finally, the results were presented in the forest plots.
Result: The pooled data demonstrated that the postoperative visual analogue score (VAS) in the LB group was not significantly different compared with that in the TPAI group at every time period after TKA. The liposomal bupivacaine group had significantly lower consumption of morphine equivalents 24 to 72 h postoperatively and reduced incidence of nausea and vomiting after TKA compared with the TPAI group. Finally, the length of hospital stay in the two groups was not significantly different.
Conclusion: Liposomal bupivacaine did not yield different results on the visual analogue scale compared with traditional peri-articular injection after total knee arthroplasty. However, liposomal bupivacaine was preferred in terms of lower consumption of morphine equivalents 24-72 h postoperatively and lower incidence of nausea and vomiting after total knee arthroplasty.
Keywords: Liposomal bupivacaine; Meta-analysis; Pain control; Randomized controlled trial; Total knee arthroplasty; Traditional peri-articular injection.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures









Similar articles
-
Liposomal bupivacaine administration is not superior to traditional periarticular injection for postoperative pain management following total knee arthroplasty: a meta-analysis of randomized controlled trials.J Orthop Surg Res. 2023 Mar 16;18(1):206. doi: 10.1186/s13018-023-03699-4. J Orthop Surg Res. 2023. PMID: 36922892 Free PMC article.
-
The Efficacy of Liposomal Bupivacaine Using Periarticular Injection in Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.J Arthroplasty. 2017 Apr;32(4):1395-1402. doi: 10.1016/j.arth.2016.12.025. Epub 2016 Dec 23. J Arthroplasty. 2017. PMID: 28082044
-
Comparison of peri-articular liposomal bupivacaine and standard bupivacaine for postsurgical analgesia in total knee arthroplasty: A systematic review and meta-analysis.Int J Surg. 2017 Mar;39:238-248. doi: 10.1016/j.ijsu.2017.02.011. Epub 2017 Feb 10. Int J Surg. 2017. PMID: 28192247
-
Comparison of periarticular anesthesia with liposomal bupivacaine with femoral nerve block for pain control after total knee arthroplasty: A PRISMA-compliant meta-analysis.Medicine (Baltimore). 2017 Mar;96(13):e6462. doi: 10.1097/MD.0000000000006462. Medicine (Baltimore). 2017. PMID: 28353580 Free PMC article.
-
Liposome bupivacaine for pain control after total knee arthroplasty: a meta-analysis.J Orthop Surg Res. 2016 Jul 22;11(1):84. doi: 10.1186/s13018-016-0420-z. J Orthop Surg Res. 2016. PMID: 27443874 Free PMC article.
Cited by
-
Liposomal bupivacaine does not decrease postoperative opioid use or length of hospital stay in patients undergoing anterior cervical discectomy and fusion.J Spine Surg. 2022 Sep;8(3):314-322. doi: 10.21037/jss-22-34. J Spine Surg. 2022. PMID: 36285100 Free PMC article.
-
Single-shot liposomal bupivacaine in place of rectus sheath catheters to provide non-opiate analgesia after laparotomy: a quality improvement project to reduce the need for ongoing nursing input.BMJ Open Qual. 2024 Feb 26;13(1):e002313. doi: 10.1136/bmjoq-2023-002313. BMJ Open Qual. 2024. PMID: 38413091 Free PMC article.
-
Liposomal Bupivacaine Infiltration Versus Bupivacaine Hydrochloride for the Management of Unilateral Total Knee Arthroplasty in Geriatric Patients at a 287-Bed Community Hospital.Hosp Pharm. 2021 Dec;56(6):792-796. doi: 10.1177/0018578720965427. Epub 2020 Oct 20. Hosp Pharm. 2021. PMID: 34732940 Free PMC article.
-
Clinical Effectiveness of Perineural Liposomal Bupivacaine is Not Superior to Bupivacaine Hydrochloride for the Prevention of Postoperative Pain in Orthopedic Surgery: A Systematic Review and Meta-Analysis with Trial Sequential Analysis.J Pain Res. 2025 Jul 16;18:3627-3642. doi: 10.2147/JPR.S525231. eCollection 2025. J Pain Res. 2025. PMID: 40693195 Free PMC article. Review.
-
The use of liposomal bupivacaine in fracture surgery: a review.J Orthop Surg Res. 2023 Apr 1;18(1):267. doi: 10.1186/s13018-023-03583-1. J Orthop Surg Res. 2023. PMID: 37005638 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical